Lung Cancer Clinical Trials in Kansas City, MO

Lung Cancer Clinical Trials in Kansas City, MO

View the best 10 lung cancer medical studies in Kansas City, Missouri. Access promising new therapies by applying to a Kansas City-based Lung Cancer clinical trial.

Top rated lung cancer clinical trials in Kansas City, Missouri

Here are the top 10 medical studies for lung cancer in Kansas City, Missouri

Image of CTCA at Western Regional Medical Center in Goodyear, United States.

Cisplatin +4 More

Alkylating agents

Recruiting2 awardsPhase 3
This trial is studying how well chemotherapy and radiation therapy work with or without atezolizumab in treating patients with limited stage small cell lung cancer.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Docetaxel +3 More

Anti-metabolites

Recruiting1 awardPhase 2
This trial is studying giving maintenance chemotherapy with or without local consolidation therapy to see if it works better than maintenance chemotherapy alone in treating patients with stage IV non-small cell lung cancer.
Image of Children's Hospital of Alabama in Birmingham, United States.

Thoracotomy +1 More

Procedure

Recruiting2 awardsPhase 3
This trial compares the effect of open thoracic surgery to thoracoscopic surgery in treating patients with osteosarcoma that has spread to the lung.
Image of Alaska Oncology and Hematology, LLC. in Anchorage, United States.

Sacituzumab Govitecan-hziy (SG) +3 More

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial is testing a new combination therapy for advanced or metastatic non-small-cell lung cancer (NSCLC) that has not responded to other treatments. The primary objectives are to assess the objective response rate (ORR) and to determine the recommended Phase 2 dose (RP2D) of the new therapy.
Image of Research Site in Chandler, United States.

Durvalumab +2 More

Checkpoint Inhibitor

Recruiting1 awardPhase 3
This trial is testing a new cancer treatment (durvalumab with SoC SBRT) against the current best treatment (placebo with SoC SBRT) for early stage non-small cell lung cancer.
Image of Yuma Regional Medical Center Cancer Center in Yuma, United States.

Encorafenib +1 More

Kinase Inhibitor

Recruiting1 awardPhase 2
This trial is testing a new combination therapy for patients with a specific type of lung cancer. The trial will test how well the new therapy works and if it is safe.
Image of University of Alabama at Birmingham in Birmingham, United States.

Telehealth +1 More

Behavioural Intervention

Recruiting1 award7 criteria
This trial is testing different ways to give palliative care to people with newly diagnosed lung cancer and their families.
Image of Stanford University in Palo Alto, United States.

Atezolizumab +2 More

Checkpoint Inhibitor

Recruiting2 awardsPhase 3
This trial is testing a new immunotherapy combination to see if it's more effective than another immunotherapy drug in people with NSCLC who have had chemoradiotherapy.
Image of XCancer/Dothan Hematology & Oncology in Dothan, United States.

ONC-392 +1 More

Monoclonal Antibodies

Verified
Recruiting2 awardsPhase 3
The study will test if ONC-392 is safe and well tolerated. It will also evaluate whether ONC-392 is effective in treating non-small cell lung cancer in comparison with the chemotherapy standard of care drug docetaxel.
Image of Ascension Providence Hospital /ID# 231970 in Southfield, United States.

Telisotuzumab Vedotin +1 More

Monoclonal Antibodies

Recruiting2 awardsPhase 3
This trial is assessing whether telisotuzumab vedotin is more effective than docetaxel and to evaluate the safety of telisotuzumab vedotin in adult patients with NSCLC who have previously been treated.

Popular filter options for lung-cancer kansas-city trials

Phase 3 Clinical Trials

View 57 phase 3 medical studies.

Clinical Trials With No Placebo

View 57 medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.